12.8 billion to 1.6 billion: South Korea's Olive Young copycat squeeze on indie K-beauty.
CJ Olive Young, the dominant Korean health-and-beauty (H&B) retail chain, runs about 1,350 stores plus the country's biggest online H&B platform and holds roughly 80% market share. For a small indie K-beauty brand — one or two founders, contract-manufactured stock-keeping units (SKUs), no chaebol (large family-controlled conglomerate) parent — listing on Olive Young is the only way to meet Korean shoppers and inbound tourists. The shelf toll runs 40–50% base commission, climbing to about 54% offline / 44% online once promotion fees, display-fee surcharges, "information provision" charges, and mandatory discount events stack on top. Then the chain copies the bestsellers into its own house brand at a sharper price. In July 2025 a Seoul court ruled that Olive Young's house-brand clone of indie brand Cosmoreplus's REVCELL serum had violated Korea's Unfair Competition Prevention and Trade Secret Protection Act; Cosmoreplus's quarterly sales had already fallen from 12.8 billion won to 1.6 billion won over a four-month window — an 87% collapse traceable to one private-label launch.
01The pain
Cosmoreplus, a small Korean indie K-beauty brand with one or two founders and no chaebol parent, sells a face serum called REVCELL. In November 2024 the founder filed an injunction against CJ Olive Young (the dominant Korean health-and-beauty retail chain, about 1,350 stores and ~80% market share). She said the chain's own house-brand copy (same shape, same active ingredient, sharper price) had wrecked her listing. A Seoul court agreed in July 2025 under Korea's Unfair Competition Prevention Act. Her quarterly sales had already dropped from 12.8 billion won to 1.6 billion won, an 87% collapse.1
Listing on Olive Young is the only way most indie brands meet Korean shoppers and inbound tourists. The shelf toll runs hard. Base commission lands at 40–50%. Add promotion fees, display-fee surcharges, "information provision" charges, and mandatory discount events, and the operator nets close to half of every offline sticker. Founders quoted in January 2026 trade press call this the "K-beauty toll" (K-뷰티 통행료).2,3 The private-label problem stacks on top: the same retailer ranks your weekly sales and ships a cheaper clone.
The Korea Fair Trade Commission (KFTC, the antitrust regulator) opened a fresh investigation in September 2024 into unfair-return practices and exclusivity coercion, nine months after a ~1.9 billion won fine on Olive Young for similar conduct.4 Hundreds of indie brands sit in the same trap.
Further reading
- 1 CosmeticsDesign Asia, 9 July 2025 — Seoul court rules in favour of Cosmoreplus against CJ Olive Young under the Unfair Competition Prevention and Trade Secret Protection Act; REVCELL serum quarterly sales fell from 12.8 billion won to 1.6 billion won (87% drop) over a four-month window: cosmeticsdesign-asia.com
- 2 Newsprime, 2025 — Olive Young vendor proposals carry 40–50% base commission, rising to ~54% offline / ~44% online once promotion, display, "information provision" and mandatory discount-event fees are layered on: newsprime.co.kr
- 3 Daum News (carrying Newsprime), 10 January 2026 — indie K-beauty founders quoted calling Olive Young listing fees "K-뷰티 통행료" (K-beauty toll fees): v.daum.net
- 4 Bizhankook, 2024 — Korea Fair Trade Commission opens September 2024 investigation into Olive Young's alleged unfair-return practices and exclusivity coercion; reference to December 2023 ~1.9 billion won fine on the same chain: bizhankook.com
- 5 Ksdaily, 2024 — coverage of indie-brand complaints against Olive Young's house-brand strategy: ksdaily.co.kr
- 6 Money Today, 2021 — earlier reporting on Olive Young's H&B channel dominance and indie-brand listing economics: news.mt.co.kr
- 7 Dealsite, 2024 — Olive Young commission and promotion-fee disclosures in indie-brand vendor proposals: dealsite.co.kr
Operators discussing this
These are real Korean indie K-beauty founders and operators talking about this pain in their own words. They are the reason this page exists.
-
«혼탁하다 3천원대 제품으로 만들어서 파는데 1만원대 하고 있고 굉장해»
"Murky business — they make the same product at the 3,000-won tier and sell it as if it were 10,000-won-tier. Incredible."
중소기업 제품 카피했다 판매금지 당한 올리브영 근황.jpg (Olive Young, ordered to stop selling after copying an SMB's product) · Ppomppu forum-board — 2025-07-08 Ppomppu free-board thread with six distinct posters discussing the SBS broadcast of the Olive Young copycat case; part of a multi-year arc on Ppomppu where Olive Young dominance recurs whenever a new private-label launch or KFTC action lands.
-
«수수료가 40~50%이라네요... 살인적이네요. 그래도 고객층 확보는 되니까 들어가야 하나»
"The commission is 40-50% — murderous. Still, you get access to customers, so should I list anyway?"
올리브영, 시코르 입점 수수료 너무 높네요 ㅠ (Olive Young & Chicor listing commissions are too high) · Remember professional-association forum — 2022-09-02 thread with 11 commenters on Remember, the Korean professional-networking community for working operators; same complaint recurs on Remember and adjacent operator forums on every annual KFTC anniversary and every Olive Young earnings release.
-
«올리브영의 월 네이버 검색량은 약 200만 건... 약 35% 수수료를 들고 가서 개별 브랜드의 마진은 얇아진다»
"Olive Young receives roughly 2 million Naver searches per month... they take around 35% in commission, so an individual brand's margin gets razor-thin."
화장품 사업을 하지 말아야 하는 이유 (Why you shouldn't start a cosmetics business) · i-boss forum-board — 2022-05-09 thread with nine commenters on i-boss.co.kr, a Korean marketing-and-cosmetics-operator community confirming the structural margin squeeze; the same complaint pattern recurs in fresh i-boss posts each time Olive Young raises a fee schedule.
02Who solves this today
International brand-protection and retail-intelligence vendors that an indie K-beauty founder reaches for when a dominant retailer copies a bestseller and undercuts the price. Each homepage was checked live on the date of writing. None of these vendors operates a Korea-localised, Olive-Young-channel-specific front-end at the time of writing; the packaged "Olive Young private-label early-warning + Section 10 injunction toolkit" the wedge above describes does not yet exist on the public market — which is precisely the startup opportunity.
Listed providers publicly self-market in one of the wedges named above. Inclusion is not endorsement. Considered and not included: Olive Young itself (the platform whose pricing and house-brand strategy defines the pain, not a solution to it). Korean local brand-protection law firms exist but do not productise scraping + filing as a SaaS bundle. The honest gap: an explicitly Korea-channel, Olive-Young-house-brand-watching service that ties a daily SKU scrape to a Section 10 (Unfair Competition Prevention Act) injunction draft inside 30 days — and routes the affected SKU onto Coupang Beauty plus cross-border Japan/Southeast Asia fulfillment — does not yet exist on the public market.
Report a mistake — or suggest a new solution
Spot a wrong number, dead source link, missing aspect, broken translation? Or know a vendor we should list as a solution? Tell us. The Director re-checks every report and either updates the page or writes back with a reason.
Got it — thank you.
The Director will look at your report on the next research cycle. If you left an email you'll hear back when we either update the page or decide it's not actionable (with a one-paragraph reason).
Listed companies — manage your entry. If you are one of the providers above and anything here is wrong, missing, or out of date — or you'd rather not be listed — write to us. Removal within 24 hours; corrections within 7 business days. We do not contact listed companies first; we publish what your own public marketing claims and respond when you reach out. Email contact@aikraft.com.